Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-07
1993-06-08
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514211, 514217, 5142285, 5142332, 514253, 540544, 540553, 540575, 544 61, 544118, 544238, 544263, 544319, 544326, 544334, 548237, 548239, 558414, 558425, A61K 31505, C07D48704
Patent
active
052179737
ABSTRACT:
The present invention relates to the derivatives of formula: ##STR1## as well as to their addition salts and to their use in therapy, in particular for the treatment of cardiovascular diseases, especially for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
REFERENCES:
patent: 4269980 (1981-05-01), Hardy et al.
patent: 4528288 (1985-07-01), Wade
patent: 4532242 (1985-07-01), Wade
patent: 4572910 (1986-02-01), Wade
patent: 4728652 (1988-03-01), Atwal
patent: 5073566 (1991-12-01), Lifer et al.
Oikawa, Y., Sugano, K. and Yonemitsu, O.; J. Org. Chem., 1978 43 (10), 2087-2088.
Wierenga, W. and Skulnick, H. I., J. Org. Chem., 1979, 44(2), 310-311.
Houghton, R. and Lapham, D.; Synthesis, 1982 6, 451-2.
Bram, G. and Vilkas, M.; Bull, Soc. Chim. France, 1964, (5), 945-951.
Balyakina, M. V., Zhdanovich, E. S. and Preobrazhenskii, N. A.; Tr. Vses. Nauchn, Issled. Vitam in. Inst., 1961, 7, 8-16, (Chemical Abstracts, vol. 59, 11417, 1963).
Renard, M. and Maquinay, A.; Bull. Soc. Chim. Belg., 1946, 55, 98-105.
Bruce, F. W. and Coover, H. W., J. Am. Chem. Soc., 1944, 66, 2092-94.
Eby, C. J. and Hauser, C. R., J. Am. Chem. Soc., 1957, 79, 723-5.
Sung-Eun Yoo and Kyu Yang Yi; Bull. Korean. Chem. Soc., 1989 10 (1), 112.
Durgeshwari, P. and Chaudhury, N. D.; J. Ind. Chem. Soc., 1962, 39, 735-6.
Heinz, P. and Kreglewski, A.; J. Prakt. Chem. 1963, 21 (3-4), 186-197.
Zaugg, H. E., Dunnigan, D. A., Michaels, R. J. and Swett, L. R.; J. Org. Chem., 1961, 26, 644-51.
Kagan, H. B. and Heng Suen, Y.; Bull. Soc. Chim. France, 1966 (6), 1819-22.
Rathke, M. W. and Deitch, J.; Tetrahedron Lett, 1971 (31), 2953-6.
Borries Kubel; Liebigs, Ann. Chem., 1980, 1392-1401.
Marquet, J. and Moreno-Manas, M.; Chem. Lett., 1981, 2 173-6.
Yoffe, S. T., Popov, E. M., Vatsuro, K. V. Tulikova, E. K. and Kabachnik, M. I.; Tetrahedron, 1962, 18 923-940.
Shepherd, T. M.; Chem. Ind. (London), 1970, 17 567.
Julia, M. and Chastrette, F.; Bull. Soc. Chim. France, 1962 (2), 2247.
Meyers, A. I. and Michelich, E. D.; J. Am. Chem. Soc., 1975, 97 (25) 7383.
Boots Pure Drug Co., CA:70(25):114837d (1969).
Heckles, CA:69(2):3704 (1968).
Miller, G. W. and Rose, F. L.; J. Chem. Soc., 1963, 5642-5659.
Miller, G. W. and Rose, F. L.; Chem. Soc., 1965, 3357-3368.
Miller, G. W. and Rose, F. L.; J. Chem. Soc., 1965, 3369-3372.
Brown, D. J. and Nagamatsu, T.; Aust. J. Chem. 1978(31), 2505-2515.
Brown, D. J., Grigg, G. W., Iwai, Y., Mac Andrew, K. N., Nagamatusu, T. and Van Heeswyck, R.; Aust. J. Chem., 1979(32), 2713-2726.
Konishi et al., CA96(13):103651Z (1982).
Konishi et al., CA97(7):55500W (1982).
Bru-Magniez Nicole
Nicolai Eric
Teulon Jean-Marie
Bernhardt F.
Laboratoires UPSA
Shah Mukund J.
LandOfFree
Triazolopyrimidine derivatives which are angiotensin II receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidine derivatives which are angiotensin II receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidine derivatives which are angiotensin II receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934240